Survival with up to 10-year Follow-up after Combination Therapy of Chemoembolization and Radiofrequency Ablation for the Treatment of Hepatocellular Carcinoma: Single-center Experience

RF ablation combined with chemoembolization is a safe and useful therapeutic option for treating HCCs. Prognostic factors detected in this study help to stratify patients who benefit from this combination therapy.